These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38618967)
41. miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis. Zhu X; Shen Z; Man D; Ruan H; Huang S Comput Math Methods Med; 2020; 2020():8209504. PubMed ID: 32952601 [TBL] [Abstract][Full Text] [Related]
42. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer. Zheng Y; Zheng Y; Lei W; Xiang L; Chen M Mol Cell Probes; 2019 Dec; 48():101445. PubMed ID: 31513891 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic role of miR-26a on cardiaorenal injury in mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway. Ni W; Zhao Y; Shen J; Yin Q; Wang Y; Li Z; Tang T; Wen Y; Zhang Y; Jiang W; Jiang L; Wei J; Gan W; Zhang A; Zhou X; Wang B; Liu BC Chin Med J (Engl); 2024 Mar; ():. PubMed ID: 38445356 [TBL] [Abstract][Full Text] [Related]
44. RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer. Sun X; Hu Y; Wu J; Shi L; Zhu L; Xi PW; Wei JF; Ding Q J Exp Clin Cancer Res; 2018 Dec; 37(1):298. PubMed ID: 30514345 [TBL] [Abstract][Full Text] [Related]
45. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899 [TBL] [Abstract][Full Text] [Related]
46. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350 [TBL] [Abstract][Full Text] [Related]
47. Long Noncoding RNA LINC01207 Promotes Colon Cancer Cell Proliferation and Invasion by Regulating miR-3125/TRIM22 Axis. Liu R; Zhao W; Wang H; Wang J Biomed Res Int; 2020; 2020():1216325. PubMed ID: 33299853 [TBL] [Abstract][Full Text] [Related]
48. RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon. Yu J; Navickas A; Asgharian H; Culbertson B; Fish L; Garcia K; Olegario JP; Dermit M; Dodel M; Hänisch B; Luo Y; Weinberg EM; Dienstmann R; Warren RS; Mardakheh FK; Goodarzi H Cancer Discov; 2020 Sep; 10(9):1410-1423. PubMed ID: 32513775 [TBL] [Abstract][Full Text] [Related]
49. LIMS1 risk genotype and T cell-mediated rejection in kidney transplant recipients. Caliskan Y; Karahan G; Akgul SU; Mirioglu S; Ozluk Y; Yazici H; Demir E; Dirim AB; Turkmen A; Edwards J; Savran FO; Sever MS; Kiryluk K; Gharavi A; Lentine KL Nephrol Dial Transplant; 2021 Nov; 36(11):2120-2129. PubMed ID: 33909908 [TBL] [Abstract][Full Text] [Related]
50. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway. Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109 [TBL] [Abstract][Full Text] [Related]
51. Effect and mechanism of long non-coding RNA ZEB2-AS1 in the occurrence and development of colon cancer. Guo X; Jing YM; Lou HZ; Lou QA Math Biosci Eng; 2019 Sep; 16(6):8109-8120. PubMed ID: 31698657 [No Abstract] [Full Text] [Related]
52. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1. Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138 [TBL] [Abstract][Full Text] [Related]
53. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Mongroo PS; Noubissi FK; Cuatrecasas M; Kalabis J; King CE; Johnstone CN; Bowser MJ; Castells A; Spiegelman VS; Rustgi AK Cancer Res; 2011 Mar; 71(6):2172-82. PubMed ID: 21252116 [TBL] [Abstract][Full Text] [Related]
54. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma. Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398 [TBL] [Abstract][Full Text] [Related]
55. CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA. Xiao H; Ye X; Vishwakarma V; Preet R; Dixon DA Cancer Biol Ther; 2022 Dec; 23(1):139-149. PubMed ID: 35130122 [TBL] [Abstract][Full Text] [Related]
56. Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level. Shao S; Ju M; Lei J; Lu X; Li H; Wang D; Xia C Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165179 [TBL] [Abstract][Full Text] [Related]
57. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. Cheng B; Rong A; Zhou Q; Li W J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207 [TBL] [Abstract][Full Text] [Related]
58. PDEF is a negative regulator of colon cancer cell growth and migration. Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706 [TBL] [Abstract][Full Text] [Related]
59. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-32 inhibits the proliferation, migration and invasion of human colon cancer cell lines by targeting E2F transcription factor 5. Yang F; Chen L; Wang ZJ Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4156-4163. PubMed ID: 31173286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]